Join Paid Clinical Trials for Crohn's Disease in

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : Crohn's Disease

Top of Directory » All Categories » by Illness » Crohn's Disease



  • Safety and Efficacy Study of Autologous Cultured Adipose -Derived Stem Cells for the Crohn's Fistula

    Condition:   Crohn's Fistula
    Intervention:   Drug: ADIPOPLUS
    Sponsor:   Anterogen Co., Ltd.
    Not yet recruiting - verified November 2009
  • The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients

    Condition:   Crohn's Disease
    Intervention:   Drug: Application of Adalimumab
    Sponsor:   University of Zurich
    Recruiting - verified November 2009
  • Study About the Effect of Doxycycline and Acetylcystein in the Treatment of CD-associated Fistulae

    Condition:   Crohn's Disease
    Intervention:   Procedure: Colonoscopy
    Sponsor:   University of Zurich
    Not yet recruiting - verified November 2009
  • An Audit of Patients With Crohn's Disease Treated With Infliximab (Study P06066)

    Condition:   Crohn's Disease
    Intervention:   Biological: Infliximab
    Sponsor:   Schering-Plough
    Not yet recruiting - verified November 2009
  • Schnitzler Syndrome: Clinical Study, Physiopathological and Search for Genetic Factors

    Condition:   Schnitzler Syndrome
    Intervention:  
    Sponsor:   University Hospital, Strasbourg, France
    Recruiting - verified October 2009
  • NURTURE, the Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents

    Condition:   Crohn's Disease
    Interventions:   Drug: certolizumab pegol;   Drug: certolizumab pegol;   Drug: certolizumab pegol
    Sponsor:   UCB, Inc.
    Recruiting - verified November 2009
  • SC12267 (4SC-101) for Treatment of Patients With Inflammatory Bowel Disease

    Condition:   Inflammatory Bowel Disease (IBD)
    Intervention:   Drug: SC12267 (4SC-101)
    Sponsor:   4SC AG
    Recruiting - verified November 2009
  • Remicade Safety Line (Crohn's Disease)(Study P03288)

    Condition:   Crohn's Disease
    Intervention:   Biological: Infliximab
    Sponsors:   Schering-Plough;   Centocor, Inc.
    Recruiting - verified November 2009
  • Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease

    Condition:   Crohn's Disease
    Interventions:   Drug: vedolizumab;   Other: Placebo
    Sponsor:   Millennium Pharmaceuticals, Inc.
    Recruiting - verified November 2009
  • Treatment With Infliximab in a Medical Setting (Study P05587)

    Condition:   Crohn's Disease
    Interventions:   Biological: Infliximab;   Biological: Infliximab
    Sponsor:   Schering-Plough
    Recruiting - verified October 2009
  • Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (Study P04840)

    Conditions:   Arthritis, Rheumatoid;   Spondylitis, Ankylosing;   Arthritis, Psoriatic;   Psoriasis;   Crohn's Disease
    Intervention:   Biological: Infliximab
    Sponsors:   Schering-Plough;   Centocor, Inc.
    Recruiting - verified November 2009
  • Remicade Infusion Management Program (Study P04466)

    Conditions:   Crohn Disease;   Rheumatoid Arthritis
    Intervention:   Biological: Infliximab
    Sponsors:   Schering-Plough;   Centocor, Inc.
    Recruiting - verified November 2009
  • Post Marketing Surveillance of Remicade (Study P05224)

    Conditions:   Crohn's Disease;   Ankylosing Spondylitis
    Intervention:   Biological: Infliximab
    Sponsor:   Schering-Plough
    Recruiting - verified November 2009
  • Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806

    Condition:   Crohn's Disease
    Intervention:   Biological: Adalimumab
    Sponsor:   Abbott
    Recruiting - verified October 2009
  • A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease

    Condition:   Crohn's Disease
    Interventions:   Drug: CP-690,550;   Drug: CP-690,550;   Drug: CP-690,550
    Sponsor:   Pfizer
    Recruiting - verified November 2009
  • Protein and Energy Metabolism in Pediatric Crohn's Disease

    Conditions:   Crohn's Disease;   Protein Metabolism;   Energy Metabolism
    Intervention:   Other: Stable isotope infusions
    Sponsors:   Indiana University;   GlaxoSmithKline;   Crohn's and Colitis Foundation;   National Center for Research Resources (NCRR)
    Recruiting - verified October 2009
  • A 5-Year Registry Study of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)

    Condition:   Crohn's Disease
    Intervention:   Biological: adalimumab
    Sponsor:   Abbott
    Recruiting - verified November 2009
  • Dietary Treatment of Crohn's Disease

    Conditions:   Crohn's Disease;   Inflammatory Bowel Disease
    Interventions:   Dietary Supplement: Time and attention + fructooligosaccharide placebo;   Dietary Supplement: dietary therapy + fructooligosaccharide placebo;   Dietary Supplement: Time and attention + active fructooligosaccharide supplementation
    Sponsors:   Rush University Medical Center;   National Center for Complementary and Alternative Medicine (NCCAM)
    Recruiting - verified November 2009
  • Hematopoietic Stem Cell Support in Patients With Severe Crohn's Disease

    Condition:   Crohn's Disease
    Intervention:   Procedure: Immune Ablation and Hematopoietic Stem Cell Support
    Sponsor:   Northwestern University
    Recruiting - verified November 2009
  • Crohn's Disease Stem Cell Transplantation

    Condition:   Crohn's Disease
    Intervention:   Procedure: stem cell transplantation
    Sponsor:   Northwestern University
    Recruiting - verified November 2009
    • Menu
    Find Paid Clinical Trials